Factors associated with refractive outcome in children treated with bevacizumab for retinopathy of prematurity: the importance of retinal vascularization-Reference-Cited by-同舟云学术

Factors associated with refractive outcome in children treated with bevacizumab for retinopathy of prematurity: the importance of retinal vascularization

Published:2022-05-17 Issue:10 Volume:42 Page:3199-3210
ISSN:1573-2630
Container-title:International Ophthalmology
language:en
Short-container-title:Int Ophthalmol

Author:

Bayramoglu Sadik Etka^ORCID,Sayin Nihat^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s10792-022-02321-6.pdf

Reference31 articles.

1. Cryotherapy for Retinopathy of Prematurity Cooperative Group (1990) Multicenter trial of cryotherapy for retinopathy of prematurity: one-year outcome: structure and function. Arch Ophthalmol 108(10):1408–1416. https://doi.org/10.1001/archopht.1990.01070120056029

2. Early Treatment for Retinopathy of Prematurity Cooperative Group (2003) Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121:1684–1695. https://doi.org/10.1001/archopht.121.12.1684

3. Mintz-Hittner HA, Kennedy KA, Chuang AZ (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364(7):603–615. https://doi.org/10.1056/NEJMoa1007374

4. Lok JY, Yip WW, Luk AS, Chin JK, Lau HH, Young AL (2018) Visual outcome and refractive status in first 3 years of age in preterm infants suffered from laser-treated type 1 retinopathy of prematurity (ROP): a 6-year retrospective review in a tertiary centre in Hong Kong. Int Ophthalmol 38(1):163–169. https://doi.org/10.1007/s10792-016-0439-5

5. Geloneck MM, Chuang AZ, Clark WL et al (2014) Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. JAMA ophthalmology 132(11):1327–1333. https://doi.org/10.1001/jamaophthalmol.2014.2772

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myopia dominance in preterm infants without and with retinopathy of prematurity: Indian Twin Cities ROP study (ITCROPS) report number 15;Acta Ophthalmologica;2024-08-16

2. Quantitative Evaluation of Progression of Retinal Vascularization After 60 Weeks Postmenstrual Age in Infants Treated With Bevacizumab;Ophthalmic Surgery, Lasers and Imaging Retina;2023-07

3. Refractive outcomes following unilateral laser treatment for type 1 retinopathy of prematurity;Journal of American Association for Pediatric Ophthalmology and Strabismus;2022-10

4. Relationship between refractive outcomes and quantitative retinal vascularization and severity of plus disease in eyes treated with intravitreal bevacizumab;Indian Journal of Ophthalmology;2022